Target intelligence / Profile preview

Nerve Growth Factor Receptor TrkA (TrkA)

Target
TrkA
Molecular classification
Receptor tyrosine kinase (RTK), Receptor
01

Overview

Nerve Growth Factor Receptor TrkA is a receptor tyrosine kinase that binds NGF with high affinity and mediates most of NGF's biological effects, including neuronal survival, differentiation, and pain perception. It is involved in various diseases, including congenital insensitivity to pain, intellectual disability, and certain cancers, making it a target for therapeutic intervention.

Other names
Tropomyosin receptor kinase Ahigh affinity nerve growth factor receptorneurotrophic tyrosine kinase receptor type 1TRK1-transforming tyrosine kinase protein
02

Mechanism of action

NGF binding induces receptor dimerization and autophosphorylation, activating downstream signaling pathways (Ras/MAPK, PI3K/Akt, PLCγ) that regulate neuronal survival, differentiation, and other functions.

03

Biological functions

Signal transductionNeuronal differentiationNeuron survivalCell proliferationNociceptionInhibition of apoptosis
04

Disease associations

Congenital insensitivity to pain with anhidrosis (CIPA)Intellectual disability/cognitive impairmentNeuroblastomaPapillary thyroid carcinomaCancerPain
05

Safety considerations

Potential for off-target effects when developing TrkA inhibitors for pain management.Development of resistance to targeted therapies in cancer due to mutations in NTRK1 or bypass mechanisms.

Beyond the preview

Go deeper on Nerve Growth Factor Receptor TrkA (TrkA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerve Growth Factor Receptor TrkA (TrkA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call